← Back to Patent Explorer
US5620469A Expired / Lapsed US ⏱️ 0.0 years remaining

Stepped cardioversion system for an implantable cardioverter defibrillator

Assignee: MGC Diagnostics Corp
•
Filing: 1994-10-11
•
Granted: 1997-04-15
•
Expires: 2014-10-11
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method and apparatus for treating ventricular tachycardia arrhythmias using an ICD system delivers a series of stepped cardioversion pulses that include at least a first and second cardioversion countershock of low energy values that are less than about 5 joules. The energy values of each cardioversion countershocks increase in stepped progressions such that the low energy value of the first cardioversion countershock is less than the second and all subsequent cardioversion countershocks. The use of a series of stepped cardioversion pulses minimizes the possibility of "overstimulating" heart cells in any reentrant loop that are causing the ventricular tachycardia. As a result, the possibility of inducing fibrillation by the cardioversion therapy is significantly decreased. The leading edge of each of the series of stepped cardioversion pulses is sufficient to just stimulate any heart cells that are in phase 4, but is not strong enough to stimulate heart cells that are in phase 3. Thus, if a reentrant loop is within the reaches of the leading edge of a pulse, that reentrant loop is converted without the possibility of inducing fibrillation.

Inventors

  • 👤 Mark W. Kroll

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 18:32
CPC Classifications
A; A61; A61N; A61N1/00; A61N1/18; A61N1/32; A61N1/38; A61N1/39; A61N1/3956; A61N1/3918

Claims Analysis

Total Claims: 28
Claim 1
Independent Claim 163 words
A method of operating an implantable cardioverter defibrillator system to treat ventricular tachycardias, the implantable cardioverter defibrillator system being a self-contained human implantable device that includes a high voltage pulse-generating capacitor system for storing an electrical charge, an energy system for internally charging the pulse-generating capacitor system, a detection system for detecting a ventricular tachycardia in a human patient and a control system for selectively discharging the electrical charge as an electrical countershock to be delivered through at least two electrodes adapted for implantation in the human patient in response to the detection means, the method comprising the device-implemented step of: (a) delivering a first cardioversion countershock of a first low energy value of less than about 4.99 joules from the pulse-generating capacitor system; and (b) delivering at least a second cardioversion countershock of a second low energy value of less than about 4.99 joules from the pulse-generating capacitor system, the second low energy value being greater than the first low energy value.
Claim 2
Independent Claim 163 words
A method of operating an implantable cardioverter defibrillator system to treat ventricular tachycardias, the implantable cardioverter defibrillator system being a self-contained human implantable device that includes a high voltage pulse-generating capacitor system for storing an electrical charge, an energy system for internally charging the pulse-generating capacitor system, a detection system for detecting a ventricular tachycardia in a human patient and a control system for selectively discharging the electrical charge as an electrical countershock to be delivered through at least two electrodes adapted for implantation in the human patient in response to the detection means, the method comprising the device-implemented step of: (a) delivering a first cardioversion countershock of a first low energy value of less than about 4.99 joules from the pulse-generating capacitor system; and (b) delivering at least a second cardioversion countershock of a second low energy value of less than about 4.99 joules from the pulse-generating capacitor system, the second low energy value being greater than the first low energy value.
Claim 3
Dependent Claim 22 words
The method of claim 1 wherein the second cardioversion countershock is delivered within less than one second from the first cardioversion countershock.
Claim 4
Dependent Claim 30 words
The method of claim 1 wherein the first cardioversion countershock produces an electrical field adjacent the electrodes through which the countershock is delivered that is less than about 2.5 V/cm.
Claim 5
Dependent Claim 17 words
The method of claim 1 wherein the first low energy value is less than about 2 joules.
Claim 6
Dependent Claim 22 words
The method of claim 1 wherein the first low energy value has an initial voltage value of less than about 20 V.
Claim 7
Dependent Claim 22 words
The method of claim 5 wherein the first low energy value has an initial voltage value of less than about 10 V.
Claim 8
Dependent Claim 35 words
The method of claim 1 wherein at least three cardioversion countershocks are delivered in step (b) each having a low energy value that is larger than the low energy value of the preceding cardioversion countershock.
Claim 9
Dependent Claim 23 words
The method of claim 1 wherein the second cardioversion countershock is spaced apart from the first cardioversion countershock by at least 0.25 seconds.
Claim 10
Dependent Claim 32 words
The method of claim 1 wherein the second cardioversion countershock has a voltage value that is between two times to five times greater than a voltage value of the first cardioversion countershock.
Claim 11
Dependent Claim 29 words
The method of claim 9 wherein the second cardioversion countershock has a voltage value that is about three times greater than a voltage value of the first cardioversion countershock.
Claim 12
Dependent Claim 29 words
The method of claim 1 further comprising the step of: (c) confirming detection of a continued ventricular tachycardia prior to delivery of the second cardioversion countershock in step (b).
Claim 13
Dependent Claim 32 words
The method of claim 10 further comprising the step of: (d) upon detection of the continued ventricular tachycardia in step (c), repeating step (a) within 1 second prior to performing step (b).
Claim 14
Dependent Claim 162 words
An improved implantable cardioverter defibrillator system for treating ventricular tachycardias, the implantable cardioverter defibrillator system being a self-contained human implantable device that includes a high voltage pulse-generating capacitor means for storing an electrical charge, an energy means for internally charging the pulse-generating capacitor means, means for detecting a ventricular tachycardia in a human patient and a control means for selectively discharging the electrical charge as an electrical countershock to be delivered through at least two electrodes adapted for implantation in the human patient in response to a means for detecting, the improvement comprising: the control means further including: means for delivering a first cardioversion countershock of a first low energy value of less than about 4.99 joules from the pulse-generating capacitor means; and means for delivering at least a second cardioversion countershock of a second low energy value of less than about 4.99 joules from the pulse-generating capacitor means, the second low energy value being greater than the first low energy value.
Claim 15
Dependent Claim 162 words
An improved implantable cardioverter defibrillator system for treating ventricular tachycardias, the implantable cardioverter defibrillator system being a self-contained human implantable device that includes a high voltage pulse-generating capacitor means for storing an electrical charge, an energy means for internally charging the pulse-generating capacitor means, means for detecting a ventricular tachycardia in a human patient and a control means for selectively discharging the electrical charge as an electrical countershock to be delivered through at least two electrodes adapted for implantation in the human patient in response to a means for detecting, the improvement comprising: the control means further including: means for delivering a first cardioversion countershock of a first low energy value of less than about 4.99 joules from the pulse-generating capacitor means; and means for delivering at least a second cardioversion countershock of a second low energy value of less than about 4.99 joules from the pulse-generating capacitor means, the second low energy value being greater than the first low energy value.
Claim 16
Dependent Claim 23 words
The system of claim 13 wherein control means delivers the second cardioversion countershock within less than one second from the first cardioversion countershock.
Claim 17
Dependent Claim 21 words
The system of claim 13 wherein the control means limits the first low energy value is less than about 2 joules.
Claim 18
Dependent Claim 26 words
The system of claim 13 wherein the control means limits the first low energy value to an initial voltage value of less than about 20 V.
Claim 19
Dependent Claim 26 words
The system of claim 16 wherein the control means limits the first low energy value to an initial voltage value of less than about 10 V.
Claim 20
Dependent Claim 43 words
The system of claim 13 wherein the control means delivers the first cardioversion countershock at a voltage such that the first cardioversion countershock produces an electrical field adjacent the electrodes through which the countershock is delivered that is less than about 2.5 V/cm.
Claim 21
Dependent Claim 41 words
The system of claim 13 wherein the means for delivering at least the second cardioversion countershock delivers at least three cardioversion countershocks, each having a low energy value that is larger than the low energy value of the preceding cardioversion countershock.
Claim 22
Dependent Claim 32 words
The system of claim 13 wherein control means delivers the second cardioversion countershock such that the second cardioversion countershock is spaced apart from the first cardioversion countershock by at least 0.25 seconds.
Claim 23
Dependent Claim 36 words
The system of claim 13 wherein the control means delivers the second cardioversion countershock at a voltage value that is between two times to five times greater than a voltage value of the first cardioversion countershock.
Claim 24
Dependent Claim 32 words
The system of claim 21 wherein the control means delivers second cardioversion countershock at a voltage value that is about three times greater than a voltage value of the first cardioversion countershock.
Claim 25
Dependent Claim 28 words
The system of claim 13 wherein the control means further comprises: means for confirming detection of a continued ventricular tachycardia prior to delivery of the second cardioversion countershock.
Claim 26
Dependent Claim 34 words
The system of claim 23 wherein the control means comprises: means for redelivering the first cardioversion countershock within 1 second prior to delivering the second cardioversion countershock upon detection of the continued ventricular tachycardia.
Claim 27
Dependent Claim 33 words
The system of claim 21 wherein the pulse-generating capacitor means comprises: a first capacitor means for delivering the first and second cardioversion countershocks; and a second capacitor means for delivering a defibrillation countershock.
Claim 28
Dependent Claim 26 words
The system of claim 25 wherein the first capacitor means has an effective capacitance that is smaller than an effective capacitance of the second capacitor means.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2000-04-14 2000-10-14 2001-04-15 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2004-04-14 2004-10-14 2005-04-15 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2008-04-14 2008-10-14 2009-04-15 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag